Novo Nordisk A/S

Ticker: NOVO.B
Meeting date: 21/03/2024
Meeting type: Annual
Proposal Mgt rec Vote
Management proposals
1 Receive Report of Board None None
2 Accept Financial Statements and Statutory Reports For For
3 Approve Allocation of Income and Dividends of DKK 6.40 Per Share For For
4 Approve Remuneration Report (Advisory Vote) For For
5.1 Approve Remuneration of Directors in the Amount of DKK 3.4 Million for the Chairman, DKK 1.7 Million for the Vice Chairman and DKK 840,000 for Other Directors; Approve Remuneration for Committee Work For For
5.2a Approve Indemnification of Board of Directors For For
5.2b Approve Indemnification of Executive Management For For
5.2c Amend Articles Re: Indemnification Scheme For For
5.3 Approve Guidelines for Incentive-Based Compensation for Executive Management and Board For For
6.1 Reelect Helge Lund (Chair) as Director For For
6.2 Reelect Henrik Poulsen (Vice Chair) as Director For For
6.3a Reelect Laurence Debroux as Director For For
6.3b Reelect Andreas Fibig as Director For For
6.3c Reelect Sylvie Gregoire as Director For For
6.3d Reelect Kasim Kutay as Director For For
6.3e Reelect Christina Law as Director For For
6.3f Reelect Martin Mackay as Director For For
7 Ratify Deloitte as Auditor For For
8.1 Approve DKK 4.5 Million Reduction in Share Capital via Share Cancellation of B Shares For For
8.2 Authorize Share Repurchase Program For For
8.3 Approve Creation of DKK 44.7 Million Pool of Capital with Preemptive Rights; Approve Creation of DKK 44.7 Million Pool of Capital without Preemptive Rights; Maximum Increase in Share Capital under Both Authorizations up to DKK 44.7 Million For For
9 Other Business None None

Disclaimer

This page contains certain information as to the voting intentions of Norges Bank in its role as manager of the Government Pension Fund Global. This disclosure is provided to promote transparency as to Norges Bank’s engagement with investee companies, and in view of its approach to responsible investing. Norges Bank’s voting intention is an internal decision and has not been agreed with any third party. Please note the following:

  • This disclosure is provided for information purposes only. It does not constitute advice and should not be taken as a recommendation or an instruction on any matter, including whether any relevant third party should buy, sell or retain shares, or how any third party should exercise any voting rights they may have. Any person who wishes to obtain advice should seek this from a professional adviser. This disclosure is not a proxy solicitation and is not intended to influence the vote of other shareholders.
  • No reliance should be placed on this information or its accuracy, and Norges Bank accepts no responsibility or liability for any action taken or not taken on the basis of this information. Any relevant third party should form their own views based on their own analysis of the relevant facts and circumstances.
  • To be clear, Norges Bank has no duty of care in respect of any third party who decides to view this disclosure, which shall be done entirely at their own risk.
  • Any information in this disclosure is subject to change without notice. In particular, be aware that Norges Bank’s intentions and the holdings of the Government Pension Fund Global may change over time and, to the extent permitted by applicable law, Norges Bank disclaims any responsibility to update this information as a result of such changes or for any other reason.
  • Securities lending or other activity may mean that the votes cast by Norges Bank are significantly different than its economic or published holding of shares, or significantly different from its holding at the date of this disclosure. No assumption should be made or reliance placed on the number of votes that will be cast.
  • Norges Bank is not subject to any prohibition on securities lending, trading or other activity as a result of this disclosure at any point prior to or after the publication of this disclosure.
Go back to search page